Public health, innovation, intellectual property and trade

Technology transfer

Transfer of health-related technologies to developing countries can enable recipient countries to produce the product locally and may result in increased access to the product and improved health. This technology transfer can take several forms, ranging from license agreements, provision of information, know-how and performance skills, to technical materials and equipment.

Publications on local production for access to medical products

The aim of this work was to develop a framework that could bring together and guide policymakers and others from all relevant fields to support the local production of medicines, vaccines and diagnostics in a manner that should improve access maximizing the potential to improve public health.

PHI’s role in transfer of health-related technology

Improving access to medicines in developing countries through technology transfer related to medical products and local production. There are two main streams of activity.

Technology transfer policy

This includes:

  • Commissioned research, workshops, analysis and reports
  • Policy development identifying political, economic, social, technological, legal and environmental conditions that are conducive to successful technology transfer

Facilitating technology transfer

This includes:

  • Mapping of appropriate technologies and assessment of freedom-to-operate
  • License negotiation on behalf of developing country manufacturers
  • Establishment of centers of excellence to provide training and documentation on manufacturing processing
  • Provision of technical support to developing country manufacturers
  • Coordination of network of experts
  • Training and capacity building



Public health, innovation, intellectual property and trade

Dr Suzanne Hill
Director, EMP
Essential Medicines and Health Products (EMP)

Dr Marie-Paule Kieny
Assistant Director-General, HIS
Health Systems and Innovation (HIS)